BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X, d'Ortho MP, Launois S, Lignot S, Bourgin P, Nogues B, Rey M, Bayard S, Scholz S, Lavault S, Tubert-Bitter P, Saussier C, Pariente A; Narcoflu-VF study group. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 2013;136:2486-96. [PMID: 23884811 DOI: 10.1093/brain/awt187] [Cited by in Crossref: 163] [Cited by in F6Publishing: 126] [Article Influence: 18.1] [Reference Citation Analysis]
Number Citing Articles
1 Takenoshita S, Sakai N, Chiba Y, Matsumura M, Yamaguchi M, Nishino S. An overview of hypocretin based therapy in narcolepsy. Expert Opinion on Investigational Drugs 2018;27:389-406. [DOI: 10.1080/13543784.2018.1459561] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
2 Dauvilliers Y, Jaussent I, Lecendreux M, Scholz S, Bayard S, Cristol JP, Blain H, Dupuy AM. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study. Brain Behav Immun 2014;37:260-6. [PMID: 24394344 DOI: 10.1016/j.bbi.2013.12.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
3 Schinkelshoek MS, Fronczek R, Kooy-Winkelaar EMC, Petersen J, Reid HH, van der Heide A, Drijfhout JW, Rossjohn J, Lammers GJ, Koning F. H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls. J Neuroimmunol 2019;332:167-75. [PMID: 31048269 DOI: 10.1016/j.jneuroim.2019.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
4 Oberle D, Pavel J, Mayer G, Geisler P, Keller-Stanislawski B; German Narcolepsy Study Group. Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany. Sleep Med 2017;34:71-83. [PMID: 28522102 DOI: 10.1016/j.sleep.2017.02.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
5 Lecendreux M, Churlaud G, Pitoiset F, Regnault A, Tran TA, Liblau R, Klatzmann D, Rosenzwajg M. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells. PLoS One 2017;12:e0169836. [PMID: 28107375 DOI: 10.1371/journal.pone.0169836] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
6 Vaughn DW, Seifert H, Hepburn A, Dewe W, Li P, Drame M, Cohet C, Innis BL, Fries LF. Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials. Hum Vaccin Immunother 2014;10:2942-57. [PMID: 25483467 DOI: 10.4161/21645515.2014.972149] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
7 Sturkenboom MC. The narcolepsy-pandemic influenza story: Can the truth ever be unraveled? Vaccine 2015;33:B6-B13. [DOI: 10.1016/j.vaccine.2015.03.026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
8 Zhang Z, Dauvilliers Y, Plazzi G, Mayer G, Lammers GJ, Santamaria J, Partinen M, Overeem S, Del Rio Villegas R, Sonka K, Peraita-Adrados R, Heinzer R, Wierzbicka A, Högl B, Manconi M, Feketeova E, da Silva AM, Bušková J, Bassetti CLA, Barateau L, Pizza F, Antelmi E, Gool JK, Fronczek R, Gaig C, Khatami R. Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis. Nat Sci Sleep 2022;14:1031-47. [PMID: 35669411 DOI: 10.2147/NSS.S359980] [Reference Citation Analysis]
9 Jacob L, Dauvilliers Y. La narcolepsie avec cataplexie : une maladie auto-immune ? Med Sci (Paris) 2014;30:1136-43. [DOI: 10.1051/medsci/20143012017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, Leu-semenescu S, Jaussent I, Dauvilliers Y. Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology 2016;88:93-100. [DOI: 10.1212/wnl.0000000000003432] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
11 Nolan T, Izurieta P, Lee BW, Chan PC, Marshall H, Booy R, Drame M, Vaughn DW. Heterologous prime-boost vaccination using an AS03B-adjuvanted influenza A(H5N1) vaccine in infants and children<3 years of age. J Infect Dis 2014;210:1800-10. [PMID: 24973461 DOI: 10.1093/infdis/jiu359] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
12 Kosalaraksa P, Jeanfreau R, Frenette L, Drame M, Madariaga M, Innis BL, Godeaux O, Izurieta P, Vaughn DW. AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial. J Infect Dis 2015;211:801-10. [PMID: 25293368 DOI: 10.1093/infdis/jiu548] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
13 Sasaki E, Momose H, Hiradate Y, Mizukami T, Hamaguchi I. Establishment of a novel safety assessment method for vaccine adjuvant development. Vaccine 2018;36:7112-8. [PMID: 30318166 DOI: 10.1016/j.vaccine.2018.10.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Johnson TP, Nath A. Neurological syndromes driven by postinfectious processes or unrecognized persistent infections. Curr Opin Neurol 2018;31:318-24. [PMID: 29547402 DOI: 10.1097/WCO.0000000000000553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
15 Ferguson D, Wrigley S, Purcell E, Keane S, McGinn B, O'Malley S, Lynch B, Crowe C. Single center analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period. J Clin Sleep Med 2021;17:885-95. [PMID: 33289477 DOI: 10.5664/jcsm.9052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Juvodden HT, Alnæs D, Lund MJ, Agartz I, Andreassen OA, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Widespread white matter changes in post-H1N1 patients with narcolepsy type 1 and first-degree relatives. Sleep 2018;41. [DOI: 10.1093/sleep/zsy145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
17 Oberle D, Drechsel-Bäuerle U, Schmidtmann I, Mayer G, Keller-Stanislawski B. Incidence of Narcolepsy in Germany. Sleep 2015;38:1619-28. [PMID: 25902804 DOI: 10.5665/sleep.5060] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
18 Pariente A, Bezin J. Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects. Therapie 2021;76:305-9. [PMID: 34119319 DOI: 10.1016/j.therap.2021.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Thebault S, Waters P, Snape MD, Cottrell D, Darin N, Hallböök T, Huutoniemi A, Partinen M, Pollard AJ, Vincent A. Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination. PLoS One 2015;10:e0129555. [PMID: 26090827 DOI: 10.1371/journal.pone.0129555] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
20 Joubert B, Dalmau J. The role of infections in autoimmune encephalitides. Revue Neurologique 2019;175:420-6. [DOI: 10.1016/j.neurol.2019.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
21 Ollila HM, Ravel JM, Han F, Faraco J, Lin L, Zheng X, Plazzi G, Dauvilliers Y, Pizza F, Hong SC, Jennum P, Knudsen S, Kornum BR, Dong XS, Yan H, Hong H, Coquillard C, Mahlios J, Jolanki O, Einen M, Arnulf I, Högl B, Frauscher B, Crowe C, Partinen M, Huang YS, Bourgin P, Vaarala O, Désautels A, Montplaisir J, Mack SJ, Mindrinos M, Fernandez-Vina M, Mignot E. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet 2015;96:136-46. [PMID: 25574827 DOI: 10.1016/j.ajhg.2014.12.010] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 14.0] [Reference Citation Analysis]
22 Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2015;47:44-57. [PMID: 25452148 DOI: 10.1016/j.bbi.2014.11.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
23 Verstraeten T, Cohet C, Dos Santos G, Ferreira GL, Bollaerts K, Bauchau V, Shinde V. Pandemrix™ and narcolepsy: A critical appraisal of the observational studies. Hum Vaccin Immunother 2016;12:187-93. [PMID: 26379011 DOI: 10.1080/21645515.2015.1068486] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
24 Postiglione E, Antelmi E, Pizza F, Lecendreux M, Dauvilliers Y, Plazzi G. The clinical spectrum of childhood narcolepsy. Sleep Medicine Reviews 2018;38:70-85. [DOI: 10.1016/j.smrv.2017.04.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
25 Pedersen NW, Holm A, Kristensen NP, Bjerregaard AM, Bentzen AK, Marquard AM, Tamhane T, Burgdorf KS, Ullum H, Jennum P, Knudsen S, Hadrup SR, Kornum BR. CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun 2019;10:837. [PMID: 30783092 DOI: 10.1038/s41467-019-08774-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 14.3] [Reference Citation Analysis]
26 Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollmächer T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39. [DOI: 10.1038/s41582-019-0226-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 37.7] [Reference Citation Analysis]
27 Latorre D, Federica S, Bassetti CLA, Kallweit U. Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation. Semin Immunopathol 2022. [PMID: 35445831 DOI: 10.1007/s00281-022-00933-9] [Reference Citation Analysis]
28 Ahmed SS, Schur PH, Macdonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. Journal of Autoimmunity 2014;50:1-11. [DOI: 10.1016/j.jaut.2014.01.033] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 11.5] [Reference Citation Analysis]
29 Black SW, Kilduff TS. H1N1 infection of sleep/wake regions results in narcolepsy-like symptoms. Proc Natl Acad Sci USA 2016;113:476-7. [DOI: 10.1073/pnas.1524150113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Wilkins AL, Kazmin D, Napolitani G, Clutterbuck EA, Pulendran B, Siegrist CA, Pollard AJ. AS03- and MF59-Adjuvanted Influenza Vaccines in Children. Front Immunol 2017;8:1760. [PMID: 29326687 DOI: 10.3389/fimmu.2017.01760] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 11.4] [Reference Citation Analysis]
31 Santamaria J, Iranzo A. Sleep disorders matter in neurology. Lancet Neurol 2014;13:18-20. [PMID: 24331789 DOI: 10.1016/S1474-4422(13)70273-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Cao W, Liepkalns JS, Kamal RP, Reber AJ, Kim JH, Hofstetter AR, Amoah S, Stevens J, Ranjan P, Gangappa S, York IA, Sambhara S. RIG-I ligand enhances the immunogenicity of recombinant H7HA protein. Cell Immunol 2016;304-305:55-8. [PMID: 27106062 DOI: 10.1016/j.cellimm.2016.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
33 Duffy J, Weintraub E, Vellozzi C, DeStefano F; Vaccine Safety Datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 2014;83:1823-30. [PMID: 25320099 DOI: 10.1212/WNL.0000000000000987] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 6.4] [Reference Citation Analysis]
34 Lacroix C, Salvo F, Gras-Champel V, Gautier S, Massy N, Valnet-Rabier MB, Grandvuillemin A, Mounier C, Benkebil M, Pariente A, Jonville-Béra AP, Micallef J; French Network of Pharmacovigilance Centres. French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge. Therapie 2021;76:297-303. [PMID: 34059351 DOI: 10.1016/j.therap.2021.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kidd M. Influenza viruses: update on epidemiology, clinical features, treatment and vaccination. Curr Opin Pulm Med 2014;20:242-6. [PMID: 24637227 DOI: 10.1097/MCP.0000000000000049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
36 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
37 Dye TJ, Jain SV, Kothare SV. Central Hypersomnia. Semin Pediatr Neurol 2015;22:93-104. [PMID: 26072339 DOI: 10.1016/j.spen.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
38 Harris T, Wong K, Stanford L, Fediurek J, Crowcroft N, Deeks S. Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data. Euro Surveill 2014;19:20900. [PMID: 25232921 DOI: 10.2807/1560-7917.es2014.19.36.20900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
39 Barker CI, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis 2014;14:227-38. [PMID: 24360892 DOI: 10.1016/S1473-3099(13)70238-X] [Cited by in Crossref: 62] [Cited by in F6Publishing: 23] [Article Influence: 6.9] [Reference Citation Analysis]
40 Zhang M, Inocente CO, Villanueva C, Lecendreux M, Dauvilliers Y, Lin JS, Arnulf I, Gustin MP, Thieux M, Franco P. Narcolepsy with cataplexy: Does age at diagnosis change the clinical picture? CNS Neurosci Ther 2020. [PMID: 32761857 DOI: 10.1111/cns.13438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Rives-Lange C, Karsenty A, Chantereau H, Oderda L, Dubern B, Lecendreux M, Tounian P. [Narcolepsy in sleepy obese children. Two case reports]. Arch Pediatr 2016;23:603-6. [PMID: 27133373 DOI: 10.1016/j.arcped.2016.03.012] [Reference Citation Analysis]
42 Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med Rev 2018;38:177-86. [PMID: 28847694 DOI: 10.1016/j.smrv.2017.06.006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 16.6] [Reference Citation Analysis]
43 Meskus M, Oikkonen V. Embodied material encounters and the ambiguous promise of biomedical futures: The case of biologically derived medicines. New Genetics and Society 2020;39:441-58. [DOI: 10.1080/14636778.2020.1778459] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Song JH, Kim TW, Um YH, Hong SC. Narcolepsy: Association with H1N1 Infection and Vaccination. Sleep Med Res 2016;7:43-7. [DOI: 10.17241/smr.2016.00101] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, Láinez M, Medina MT, Meshram C, Mizusawa H, Öztürk S, Wasay M; WFN Environmental Neurology Specialty Group. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci 2020;414:116884. [PMID: 32464367 DOI: 10.1016/j.jns.2020.116884] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 44.5] [Reference Citation Analysis]
46 Durier C, Desaint C, Lelièvre JD, Silbermann B, Pialoux G, Cuzin L, Bonnet B, Poizot-Martin I, Bouakane A, Paul C, Grabar S, Spire B, Meyer L, Launay O; ANRS/VRI COHVAC Study Group. Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials. AIDS 2019;33:2061-71. [PMID: 31306171 DOI: 10.1097/QAD.0000000000002310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Czako R, Subbarao K. Refining the approach to vaccines against influenza A viruses with pandemic potential. Future Virol 2015;10:1033-47. [PMID: 26587050 DOI: 10.2217/fvl.15.69] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
48 Destefano F, Offit PA, Fisher A. Vaccine Safety. Plotkin's Vaccines. Elsevier; 2018. pp. 1584-1600.e10. [DOI: 10.1016/b978-0-323-35761-6.00082-1] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
49 Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C. Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study. J Clin Sleep Med 2017;13:441-53. [PMID: 28095967 DOI: 10.5664/jcsm.6500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
50 Ambati A, Luo G, Pradhan E, Louis J, Lin L, Leib RD, Ollila HM, Poiret T, Adams C, Mignot E. Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines. Vaccines (Basel) 2020;8:E630. [PMID: 33142956 DOI: 10.3390/vaccines8040630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Saariaho AH, Vuorela A, Freitag TL, Pizza F, Plazzi G, Partinen M, Vaarala O, Meri S. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. J Autoimmun 2015;63:68-75. [PMID: 26227560 DOI: 10.1016/j.jaut.2015.07.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
52 Patrono A, Renzetti S, Manco A, Brunelli P, Moncada SM, Macgowan MJ, Placidi D, Calza S, Cagna G, Rota M, Memo M, Tira M, Lucchini RG. COVID-19 Aftermath: Exploring the Mental Health Emergency among Students at a Northern Italian University. IJERPH 2022;19:8587. [DOI: 10.3390/ijerph19148587] [Reference Citation Analysis]
53 Wijnans L, Dodd C, de Ridder M, Romio S, Weibel D, Overeem S, Lammers GJ, Bonhoeffer J, Black S, Sturkenboom M. Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias. Expert Rev Vaccines 2016;15:573-84. [PMID: 26967200 DOI: 10.1586/14760584.2016.1164045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
54 Scheer D, Schwartz SW, Parr M, Zgibor J, Sanchez-Anguiano A, Rajaram L. Prevalence and incidence of narcolepsy in a US health care claims database, 2008-2010. Sleep 2019;42:zsz091. [PMID: 31004158 DOI: 10.1093/sleep/zsz091] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
55 Pizza F, Peltola H, Sarkanen T, Moghadam KK, Plazzi G, Partinen M. Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases. Sleep Medicine 2014;15:262-5. [DOI: 10.1016/j.sleep.2013.09.021] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
56 Lind A, Freyhult E, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Lima Bomfim I, Fink K, Fex M, Törn C, Elding Larsson H, Lernmark Å. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls. Viral Immunol 2017;30:590-600. [PMID: 28796576 DOI: 10.1089/vim.2017.0066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
57 Bhattacharjee B, Acharya T. "The COVID-19 Pandemic and its Effect on Mental Health in USA - A Review with Some Coping Strategies". Psychiatr Q 2020;91:1135-45. [PMID: 32829449 DOI: 10.1007/s11126-020-09836-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
58 Arango M, Kivity S, Shoenfeld Y. Is narcolepsy a classical autoimmune disease? Pharmacological Research 2015;92:6-12. [DOI: 10.1016/j.phrs.2014.10.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
59 Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015;14:318-28. [PMID: 25728441 DOI: 10.1016/S1474-4422(14)70218-2] [Cited by in Crossref: 107] [Cited by in F6Publishing: 34] [Article Influence: 15.3] [Reference Citation Analysis]
60 Khatami R, Luca G, Baumann CR, Bassetti CL, Bruni O, Canellas F, Dauvilliers Y, Del Rio-villegas R, Feketeova E, Ferri R, Geisler P, Högl B, Jennum P, Kornum BR, Lecendreux M, Martins-da-silva A, Mathis J, Mayer G, Paiva T, Partinen M, Peraita-adrados R, Plazzi G, Santamaria J, Sonka K, Riha R, Tafti M, Wierzbicka A, Young P, Lammers GJ, Overeem S; European Narcolepsy Network. The European Narcolepsy Network (EU-NN) database. J Sleep Res 2016;25:356-64. [DOI: 10.1111/jsr.12374] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
61 Johansen K, Brasseur D, Macdonald N, Nohynek H, Vandeputte J, Wood D, Neels P. Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines? Biologicals 2016;44:276-80. [DOI: 10.1016/j.biologicals.2016.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
62 Fraigne JJ, Grace KP, Horner RL, Peever J. Mechanisms of REM sleep in health and disease: . Current Opinion in Pulmonary Medicine 2014;20:527-32. [DOI: 10.1097/mcp.0000000000000103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Winstone AM, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, Shneerson J. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014;56:1117-23. [PMID: 25041214 DOI: 10.1111/dmcn.12522] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
64 Blomberg K, Carlsson AA, Hagberg L, Jonsson Ö, Leissner L, Eriksson MH. Quality of life and trust among young people with narcolepsy and their families, after the Pandemrix® vaccination: protocol for a case-control study. BMC Pediatr 2017;17:183. [PMID: 28835221 DOI: 10.1186/s12887-017-0935-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Zhang Z, Gool JK, Fronczek R, Dauvilliers Y, Bassetti CLA, Mayer G, Plazzi G, Pizza F, Santamaria J, Partinen M, Overeem S, Peraita-Adrados R, da Silva AM, Sonka K, Del Rio-Villegas R, Heinzer R, Wierzbicka A, Young P, Högl B, Manconi M, Feketeova E, Mathis J, Paiva T, Canellas F, Lecendreux M, Baumann CR, Lammers GJ, Khatami R. New 2013 incidence peak in childhood narcolepsy: more than vaccination? Sleep 2021;44:zsaa172. [PMID: 32909046 DOI: 10.1093/sleep/zsaa172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Brillo E, Tosto V, Giardina I, Buonomo E. Maternal tetanus, diphtheria, and acellular pertussis (Tdap) and influenza immunization: an overview. J Matern Fetal Neonatal Med 2021;34:3415-44. [PMID: 31645152 DOI: 10.1080/14767058.2019.1680633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
67 Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Safadi MA, Cruz-Valdez A, Litao S, Lim FS, de Los Santos AM, Weber MA, Tinoco JC, Mezerville MH, Faingezicht I, Kosuwon P, Lopez P, Borja-Tabora C, Li P, Durviaux S, Fries L, Dubin G, Breuer T, Innis BL, Vaughn DW. Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial. J Infect Dis 2014;210:545-57. [PMID: 24652494 DOI: 10.1093/infdis/jiu173] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
68 Bernard-Valnet R, Yshii L, Quériault C, Nguyen XH, Arthaud S, Rodrigues M, Canivet A, Morel AL, Matthys A, Bauer J, Pignolet B, Dauvilliers Y, Peyron C, Liblau RS. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A 2016;113:10956-61. [PMID: 27621438 DOI: 10.1073/pnas.1603325113] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
69 Théophile H, Moore N, Robinson P, Bégaud B, Pariente A. Vaccine Case-Population: A New Method for Vaccine Safety Surveillance. Drug Saf 2016;39:1197-209. [PMID: 27612460 DOI: 10.1007/s40264-016-0449-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Nakahashi-Ouchida R, Yuki Y, Kiyono H. Development of a nanogel-based nasal vaccine as a novel antigen delivery system. Expert Rev Vaccines 2017;16:1231-40. [PMID: 29053938 DOI: 10.1080/14760584.2017.1395702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
71 Kornum BR, Jennum P. The case for narcolepsy as an autoimmune disease. Expert Review of Clinical Immunology 2020;16:231-3. [DOI: 10.1080/1744666x.2020.1719832] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Pérez-Carbonell L, Leschziner G. Clinical update on central hypersomnias. J Thorac Dis 2018;10:S112-23. [PMID: 29445535 DOI: 10.21037/jtd.2017.10.161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
73 Kornum BR, Knudsen S, Ollila HM, Pizza F, Jennum PJ, Dauvilliers Y, Overeem S. Narcolepsy. Nat Rev Dis Primers 2017;3:16100. [PMID: 28179647 DOI: 10.1038/nrdp.2016.100] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 21.8] [Reference Citation Analysis]
74 Barateau L, Liblau R, Peyron C, Dauvilliers Y. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment. CNS Drugs 2017;31:821-34. [DOI: 10.1007/s40263-017-0464-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
75 Mohammadi S, Dolatshahi M, Zare-shahabadi A, Rahmani F. Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options. Brain Research 2019;1718:212-22. [DOI: 10.1016/j.brainres.2019.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
76 Monaca C, Franco P, Philip P, Dauvilliers Y. French consensus. Type 1 and type 2 Narcolepsy: Investigations and follow-up. Revue Neurologique 2017;173:25-31. [DOI: 10.1016/j.neurol.2016.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
77 Bond M, Bechter K, Müller N, Tebartz van Elst L, Meier UC. A role for pathogen risk factors and autoimmunity in encephalitis lethargica? Prog Neuropsychopharmacol Biol Psychiatry 2021;109:110276. [PMID: 33549696 DOI: 10.1016/j.pnpbp.2021.110276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Adang LA, Lynch DR, Panzer JA. Pediatric anti-NMDA receptor encephalitis is seasonal. Ann Clin Transl Neurol 2014;1:921-5. [PMID: 25540806 DOI: 10.1002/acn3.100] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
79 Juvodden HT, Viken MK, Nordstrand SEH, Viste R, Westlye LT, Thorsby PM, Lie BA, Knudsen-heier S. HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives. Sleep 2020;43:zsz239. [DOI: 10.1093/sleep/zsz239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
80 Trombetta CM, Gianchecchi E, Montomoli E. Influenza vaccines: Evaluation of the safety profile. Hum Vaccin Immunother 2018;14:657-70. [PMID: 29297746 DOI: 10.1080/21645515.2017.1423153] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
81 Oikkonen V. The 2009 H1N1 pandemic, vaccine-associated narcolepsy, and the politics of risk and harm. Health (London). [DOI: 10.1177/1363459320925880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
82 Bollaerts K, Shinde V, Dos Santos G, Ferreira G, Bauchau V, Cohet C, Verstraeten T. Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™ and Narcolepsy. PLoS One 2016;11:e0149289. [PMID: 26901063 DOI: 10.1371/journal.pone.0149289] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
83 Latorre D, Kallweit U, Armentani E, Foglierini M, Mele F, Cassotta A, Jovic S, Jarrossay D, Mathis J, Zellini F, Becher B, Lanzavecchia A, Khatami R, Manconi M, Tafti M, Bassetti CL, Sallusto F. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 2018;562:63-8. [DOI: 10.1038/s41586-018-0540-1] [Cited by in Crossref: 138] [Cited by in F6Publishing: 115] [Article Influence: 34.5] [Reference Citation Analysis]
84 Huppertz HI; Kommission für Infektionskrankheiten und Impffragen der Deutschen Akademie für Kinder- und Jugendmedizin e. V. (DAKJ). [Recommendations on the approach when unusual neurological symptoms occur in temporal association with vaccinations in childhood and adolescence]. Monatsschr Kinderheilkd 2020;:1-7. [PMID: 32836398 DOI: 10.1007/s00112-020-00975-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Ravel JM, Mignot EJM. [Narcolepsy: From the discovery of a wake promoting peptide to autoimmune T cell biology and molecular mimicry with flu epitopes]. Biol Aujourdhui 2019;213:87-108. [PMID: 31829930 DOI: 10.1051/jbio/2019026] [Reference Citation Analysis]
86 Mignot EJ. History of narcolepsy at Stanford University. Immunol Res 2014;58:315-39. [PMID: 24825774 DOI: 10.1007/s12026-014-8513-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
87 Fraigne JJ, Torontali ZA, Snow MB, Peever JH. REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology. Front Neurol 2015;6:123. [PMID: 26074874 DOI: 10.3389/fneur.2015.00123] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
88 Dietmann A, Horn MP, Schinkelshoek MS, Fronczek R, Salmen A, Bargiotas P, Lammers GJ, Khatami R, Bassetti CLA. Conventional autoantibodies against brain antigens are not routinely detectable in serum and CSF of narcolepsy type 1 and 2 patients. Sleep Med 2020;75:188-91. [PMID: 32858359 DOI: 10.1016/j.sleep.2020.08.001] [Reference Citation Analysis]
89 Tedjasukmana R. Sleep Disturbances Linked to Genetic Disorders. Sleep Medicine Clinics 2022. [DOI: 10.1016/j.jsmc.2021.10.005] [Reference Citation Analysis]
90 Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014;13:600-13. [PMID: 24849861 DOI: 10.1016/S1474-4422(14)70075-4] [Cited by in Crossref: 173] [Cited by in F6Publishing: 60] [Article Influence: 21.6] [Reference Citation Analysis]
91 De la Herrán-Arita AK, Kornum BR, Mahlios J, Jiang W, Lin L, Hou T, Macaubas C, Einen M, Plazzi G, Crowe C, Newell EW, Davis MM, Mellins ED, Mignot E. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med 2013;5:216ra176. [PMID: 24353159 DOI: 10.1126/scitranslmed.3007762] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]
92 Miyagawa T, Tokunaga K. Genetics of narcolepsy. Hum Genome Var 2019;6:4. [PMID: 30652006 DOI: 10.1038/s41439-018-0033-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
93 Nguyen XH, Dauvilliers Y, Quériault C, Perals C, Romieu-Mourez R, Paulet PE, Bernard-Valnet R, Fazilleau N, Liblau R. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients. J Autoimmun 2018;94:134-42. [PMID: 30104107 DOI: 10.1016/j.jaut.2018.07.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
94 Halsey NA, Talaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, Salmon DA. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine 2015;33 Suppl 5:F1-F67. [PMID: 26822822 DOI: 10.1016/j.vaccine.2015.10.080] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
95 Babiker MO, Prasad M. Narcolepsy in children: a diagnostic and management approach. Pediatr Neurol 2015;52:557-65. [PMID: 25838042 DOI: 10.1016/j.pediatrneurol.2015.02.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
96 Luo G, Yogeshwar S, Lin L, Mignot EJ. T cell reactivity to regulatory factor X4 in type 1 narcolepsy. Sci Rep 2021;11:7841. [PMID: 33837283 DOI: 10.1038/s41598-021-87481-8] [Reference Citation Analysis]
97 Dauvilliers Y, Evangelista E, Lopez R, Barateau L, Scholz S, Crastes de Paulet B, Carlander B, Jaussent I. Vitamin D deficiency in type 1 narcolepsy: a reappraisal. Sleep Medicine 2017;29:1-6. [DOI: 10.1016/j.sleep.2016.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
98 Bonvalet M, Ollila HM, Ambati A, Mignot E. Autoimmunity in narcolepsy. Curr Opin Pulm Med 2017;23:522-9. [PMID: 28991006 DOI: 10.1097/MCP.0000000000000426] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
99 Sarkanen T, Alakuijala A, Julkunen I, Partinen M. Narcolepsy Associated with Pandemrix Vaccine. Curr Neurol Neurosci Rep 2018;18:43. [PMID: 29855798 DOI: 10.1007/s11910-018-0851-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
100 Zandian A, Forsström B, Häggmark-månberg A, Schwenk JM, Uhlén M, Nilsson P, Ayoglu B. Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy. J Proteome Res 2017;16:1300-14. [DOI: 10.1021/acs.jproteome.6b00916] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
101 Luo G, Lin L, Jacob L, Bonvalet M, Ambati A, Plazzi G, Pizza F, Leib R, Adams CM, Partinen M, Mignot EJ. Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases. PLoS One 2017;12:e0187305. [PMID: 29220370 DOI: 10.1371/journal.pone.0187305] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
102 Raggi A, Plazzi G, Ferri R. Health-Related Quality of Life in Patients With Narcolepsy: A Review of the Literature. J Nerv Ment Dis 2019;207:84-99. [DOI: 10.1097/nmd.0000000000000918] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
103 Morcol T, Nagappan P, Bell SJD, Cawthon AG. Influenza A(H5N1) Virus Subunit Vaccine Administered with CaPNP Adjuvant Induce High Virus Neutralization Antibody Titers in Mice. AAPS PharmSciTech 2019;20:315. [PMID: 31591662 DOI: 10.1208/s12249-019-1530-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
104 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
105 Nguyen XH, Saoudi A, Liblau RS. Vaccine-associated inflammatory diseases of the central nervous system: from signals to causation. Curr Opin Neurol 2016;29:362-71. [PMID: 27023738 DOI: 10.1097/WCO.0000000000000318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
106 Kashiwagi S, Brauns T, Gelfand J, Poznansky MC. Laser vaccine adjuvants. History, progress, and potential. Hum Vaccin Immunother 2014;10:1892-907. [PMID: 25424797 DOI: 10.4161/hv.28840] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
107 Levy S, McArthur I, Crow B, Zuberi S. Factors Influencing Time to Diagnosis in Childhood Narcolepsy Type 1. J Child Neurol 2019;34:440-5. [PMID: 30913957 DOI: 10.1177/0883073819836548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Miyagawa T, Toyoda H, Hirataka A, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Imai M, Fujimura Y, Tamura Y, Ikegami A, Wada Y, Moriya S, Furuya H, Kato M, Omata N, Kojima H, Kashiwase K, Saji H, Khor S, Yamasaki M, Wada Y, Ishigooka J, Kuroda K, Kume K, Chiba S, Yamada N, Okawa M, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K. New susceptibility variants to narcolepsy identified in HLA class II region. Human Molecular Genetics 2015;24:891-8. [DOI: 10.1093/hmg/ddu480] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
109 Lecomte A, Barateau L, Pereira P, Paulin L, Auvinen P, Scheperjans F, Dauvilliers Y. Gut microbiota composition is associated with narcolepsy type 1. Neurol Neuroimmunol Neuroinflamm 2020;7:e896. [PMID: 33037102 DOI: 10.1212/NXI.0000000000000896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
110 Lacroix C, Mallaret M, Jonville-bera A. Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance Centres. Therapies 2020;75:207-13. [DOI: 10.1016/j.therap.2020.02.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Lecendreux M, Libri V, Jaussent I, Mottez E, Lopez R, Lavault S, Regnault A, Arnulf I, Dauvilliers Y. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ? J Autoimmun 2015;60:20-31. [PMID: 25892508 DOI: 10.1016/j.jaut.2015.03.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
112 Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol 2018;15:586-94. [PMID: 29503439 DOI: 10.1038/cmi.2017.151] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
113 Moresco M, Lecciso M, Ocadlikova D, Filardi M, Melzi S, Kornum BR, Antelmi E, Pizza F, Mignot E, Curti A, Plazzi G. Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease. Sleep Medicine 2018;44:53-60. [DOI: 10.1016/j.sleep.2017.11.1150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
114 Stowe J, Andrews N, Kosky C, Dennis G, Eriksson S, Hall A, Leschziner G, Reading P, Shneerson JM, Donegan K, Miller E. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Sleep 2016;39:1051-7. [PMID: 26856903 DOI: 10.5665/sleep.5752] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
115 Thebault S, Vincent A, Gringras P. Narcolepsy and H1N1 vaccination: a link? Current Opinion in Pulmonary Medicine 2013;19:587-93. [DOI: 10.1097/mcp.0b013e328365af97] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
116 Juvodden HT, Alnæs D, Lund MJ, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Hypocretin-deficient narcolepsy patients have abnormal brain activation during humor processing. Sleep 2019;42:zsz082. [DOI: 10.1093/sleep/zsz082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
117 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
118 Chandler RE. Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events. BMJ 2019;365:l2268. [PMID: 31151960 DOI: 10.1136/bmj.l2268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
119 Alakuijala A, Sarkanen T, Partinen M. Polysomnographic and actigraphic characteristics of patients with H1N1-vaccine-related and sporadic narcolepsy. Sleep Med 2015;16:39-44. [PMID: 25554349 DOI: 10.1016/j.sleep.2014.07.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
120 Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2018;2:CD001269. [PMID: 29388196 DOI: 10.1002/14651858.CD001269.pub6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 11.5] [Reference Citation Analysis]
121 Del Giudice G, Rappuoli R. Inactivated and adjuvanted influenza vaccines. Curr Top Microbiol Immunol 2015;386:151-80. [PMID: 25038938 DOI: 10.1007/82_2014_406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
122 Lecendreux M. Quality of Life in Children with Narcolepsy and Cataplexy. Sleep Medicine Clinics 2014;9:211-7. [DOI: 10.1016/j.jsmc.2014.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
123 Mignot E. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 855-872.e7. [DOI: 10.1016/b978-0-323-24288-2.00089-1] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
124 Kornum BR. Narcolepsy Type I as an autoimmune disorder. Handb Clin Neurol 2021;181:161-72. [PMID: 34238455 DOI: 10.1016/B978-0-12-820683-6.00012-9] [Reference Citation Analysis]
125 Silber MH. Autoimmune sleep disorders. Autoimmune Neurology. Elsevier; 2016. pp. 317-26. [DOI: 10.1016/b978-0-444-63432-0.00018-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
126 Chen RT, Carbery B, Mac L, Berns KI, Chapman L, Condit RC, Excler JL, Gurwith M, Hendry M, Khan AS, Khuri-Bulos N, Klug B, Robertson JS, Seligman SJ, Sheets R, Williamson AL; V3SWG. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Vaccine 2015;33:73-5. [PMID: 25305565 DOI: 10.1016/j.vaccine.2014.09.035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
127 Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nat Rev Neurol 2014;10:386-95. [DOI: 10.1038/nrneurol.2014.97] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 12.9] [Reference Citation Analysis]
128 Nordstrand SH, Hansen BH, Kamaleri Y, Nilsen KB, Rootwelt T, Karlsen T, Knudsen S. Changes in quality of life in individuals with narcolepsy type 1 after the H1N1-influenza epidemic and vaccination campaign in Norway: a two-year prospective cohort study. Sleep Medicine 2018;50:175-80. [DOI: 10.1016/j.sleep.2018.05.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
129 Shaw CA, Li D, Tomljenovic L. Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy? Immunotherapy 2014;6:1055-71. [DOI: 10.2217/imt.14.81] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
130 Oberle D, Pavel J, Keller-stanislawski B. Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in Germany. Pharmacoepidemiol Drug Saf 2017;26:1321-7. [DOI: 10.1002/pds.4292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
131 Chen RT, Moro PL, Bauwens J, Bonhoeffer J. Obstetrical and neonatal case definitions for immunization safety data. Vaccine 2016;34:5991-2. [PMID: 27554535 DOI: 10.1016/j.vaccine.2016.08.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
132 Qasrawi SQ, Albarrak AM, Alharbi AS, Nashwan S, Almeneessier AS, Pandi-Perumal SR, Alsaadi MM, BaHammam AS. Narcolepsy in Saudi patients before and after the 2009 H1N1 vaccination. The experience of 2 referral centers. Saudi Med J 2017;38:1196-200. [PMID: 29209667 DOI: 10.15537/smj.2017.12.21046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
133 Häggmark-Månberg A, Zandian A, Forsström B, Khademi M, Lima Bomfim I, Hellström C, Arnheim-Dahlström L, Hallböök T, Darin N, Lundberg IE, Uhlén M, Partinen M, Schwenk JM, Olsson T, Nilsson P. Autoantibody targets in vaccine-associated narcolepsy. Autoimmunity 2016;49:421-33. [PMID: 27206786 DOI: 10.1080/08916934.2016.1183655] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
134 Weibel D, Sturkenboom M, Black S, de Ridder M, Dodd C, Bonhoeffer J, Vanrolleghem A, van der Maas N, Lammers GJ, Overeem S, Gentile A, Giglio N, Castellano V, Kwong JC, Murray BJ, Cauch-Dudek K, Juhasz D, Campitelli M, Datta AN, Kallweit U, Huang WT, Huang YS, Hsu CY, Chen HC, Giner-Soriano M, Morros R, Gaig C, Tió E, Perez-Vilar S, Diez-Domingo J, Puertas FJ, Svenson LW, Mahmud SM, Carleton B, Naus M, Arnheim-Dahlström L, Pedersen L, DeStefano F, Shimabukuro TT. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment. Vaccine 2018;36:6202-11. [PMID: 30122647 DOI: 10.1016/j.vaccine.2018.08.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]